Literature DB >> 2204442

Biophysical chemistry of the daunomycin-DNA interaction.

J B Chaires1.   

Abstract

Daunomycin (daunorubicin) is a potent anticancer antibiotic that binds to DNA by the process of intercalation. Fundamental aspects of the physical chemistry of the daunomycin-DNA interaction are reviewed here, including the thermodynamics and kinetics of the binding reaction, and recent work that indicates that daunomycin binds preferentially to certain sites along the DNA lattice. The solution studies reviewed here combine with recent theoretical and crystallographic investigations to make the daunomycin-DNA interaction one of the best-characterized intercalation reactions. The molecular interactions that stabilize the daunomycin-DNA complex, and which contribute to its sequence preference, are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2204442     DOI: 10.1016/0301-4622(90)80008-u

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  11 in total

1.  Probing the relative orientation of molecules bound to DNA through controlled interference using second-harmonic generation.

Authors:  Benjamin Doughty; Yi Rao; Samuel W Kazer; Sheldon J J Kwok; Nicholas J Turro; Kenneth B Eisenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

2.  General analysis of competitive binding in drug-interceptor-DNA systems.

Authors:  A S Buchelnikov; A A Hernandez Santiago; M Gonzalez Flores; R Vazquez Ramirez; D B Davies; M P Evstigneev
Journal:  Eur Biophys J       Date:  2012-01-03       Impact factor: 1.733

Review 3.  Cardiotoxicity of anticancer treatments: what the cardiologist needs to know.

Authors:  Michael S Ewer; Steven M Ewer
Journal:  Nat Rev Cardiol       Date:  2010-10       Impact factor: 32.419

4.  Bis-daunomycin hydrazones: interactions with DNA.

Authors:  D R Phillips; R T Brownlee; J A Reiss; P A Scourides
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

5.  Targeting RNA by small molecules: comparative structural and thermodynamic aspects of aristololactam-β-D-glucoside and daunomycin binding to tRNA(phe).

Authors:  Abhi Das; Kakali Bhadra; Gopinatha Suresh Kumar
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

Review 6.  Liposomal daunorubicin as treatment for Kaposi's sarcoma.

Authors:  Christin E Petre; Dirk P Dittmer
Journal:  Int J Nanomedicine       Date:  2007

7.  Sequence- and structural-selective nucleic acid binding revealed by the melting of mixtures.

Authors:  Xiaochun Shi; Jonathan B Chaires
Journal:  Nucleic Acids Res       Date:  2006-01-23       Impact factor: 16.971

8.  Binding Studies of Aloe-Active Compounds with G-Quadruplex Sequences.

Authors:  Abhi Das; Sanjay Dutta
Journal:  ACS Omega       Date:  2021-07-09

9.  Cardiotoxicity of cancer therapeutics: current issues in screening, prevention, and therapy.

Authors:  Richard J Sheppard; Jenna Berger; Igal A Sebag
Journal:  Front Pharmacol       Date:  2013-03-12       Impact factor: 5.810

10.  Interaction of anthracyclines with iron responsive element mRNAs.

Authors:  Joshua C Canzoneri; Adegboyega K Oyelere
Journal:  Nucleic Acids Res       Date:  2008-10-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.